Post-IPO Equity Biotechnology Companies

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Rize Oncology develops a platform that allows to conjugate or tether donor DNA templates.

Biora Therapeutics is the biotech company.

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products.

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Aurora is an early-stage start-up company focused on bringing advanced solutions to the spinal implant market.

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.